Literature DB >> 11514011

A survey of radiotherapy quality control practice in the United Kingdom for the START trial.

K Venables1, E Winfield, A Deighton, E Aird, P Hoskin.   

Abstract

BACKGROUND AND
PURPOSE: This paper compares the quality control checks performed in departments in the United Kingdom with those recommended by the Institute of Physics and Engineering in Medicine (IPEM) in Report 81.
METHOD: The data were gathered by the quality assurance team for the START trial, during visits to individual departments. Data are compared with the frequencies suggested in IPEM report 81. Where applicable, data are also analyzed with respect to machine manufacturer.
RESULTS: All departments with linear accelerators check the output at least weekly for both photons and electrons, however 11% of departments do not perform a constancy check of the output on a daily basis. The majority of departments check flatness at gantry zero on a monthly basis. However 27% of departments never check at non-zero gantry angles. In 51% of departments no fluoroscopy checks are performed on simulators on a daily basis.
CONCLUSION: The majority of departments are following the frequencies suggested in IPEM report 81 although there are a number of discrepancies particularly for simulators. Accelerator type needs to be considered when designing quality assurance checks. In many departments more time than is currently allocated is needed on equipment, particularly simulators, to complete all of the checks suggested in Report 81.

Entities:  

Mesh:

Year:  2001        PMID: 11514011     DOI: 10.1016/s0167-8140(01)00376-0

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  8 in total

1.  Radiotherapy dosimetry audit: three decades of improving standards and accuracy in UK clinical practice and trials.

Authors:  Catharine H Clark; Edwin G A Aird; Steve Bolton; Elizabeth A Miles; Andrew Nisbet; Julia A D Snaith; Russell A S Thomas; Karen Venables; David I Thwaites
Journal:  Br J Radiol       Date:  2015-09-02       Impact factor: 3.039

2.  Quality assurance analysis of participating centres' protocol compliance to a UK multicentre hypofractionated breast (FAST) trial.

Authors:  Y Tsang; K Venables; J Yarnold
Journal:  Br J Radiol       Date:  2012-01-31       Impact factor: 3.039

3.  A survey of the practice and management of radiotherapy linear accelerator quality control in the UK.

Authors:  A Palmer; J Kearton; O Hayman
Journal:  Br J Radiol       Date:  2012-06-06       Impact factor: 3.039

Review 4.  Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie?

Authors:  Mareike K Thompson; Philip Poortmans; Anthony J Chalmers; Corinne Faivre-Finn; Emma Hall; Robert A Huddart; Yolande Lievens; David Sebag-Montefiore; Charlotte E Coles
Journal:  Br J Cancer       Date:  2018-07-31       Impact factor: 7.640

5.  The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Authors:  S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; S M Bentzen; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold
Journal:  Lancet       Date:  2008-03-19       Impact factor: 79.321

6.  The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

Authors:  S M Bentzen; R K Agrawal; E G A Aird; J M Barrett; P J Barrett-Lee; J M Bliss; J Brown; J A Dewar; H J Dobbs; J S Haviland; P J Hoskin; P Hopwood; P A Lawton; B J Magee; J Mills; D A L Morgan; J R Owen; S Simmons; G Sumo; M A Sydenham; K Venables; J R Yarnold
Journal:  Lancet Oncol       Date:  2008-03-19       Impact factor: 41.316

7.  Anthropomorphic breast phantoms for quality assurance and dose verification.

Authors:  José A Bencomo; Connel Chu; Victor M Tello; Sang Hyun Cho; Geoffrey S Ibbott
Journal:  J Appl Clin Med Phys       Date:  2004-01-01       Impact factor: 2.102

8.  Breast clinical target volume: HU-based glandular CTVs and ESTRO CTVs in modern and historical radiotherapy treatment planning.

Authors:  Marciana Nona Duma; Theresa Kulms; Stefan Knippen; Tobias Teichmann; Andrea Wittig
Journal:  Strahlenther Onkol       Date:  2021-09-03       Impact factor: 3.621

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.